S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:FEMY

Femasys (FEMY) Stock Price, News & Analysis

$1.55
+0.08 (+5.44%)
(As of 03/28/2024 ET)
Today's Range
$1.44
$1.65
50-Day Range
$0.75
$2.22
52-Week Range
$0.25
$4.75
Volume
487,880 shs
Average Volume
1.05 million shs
Market Capitalization
$33.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.67

Femasys MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
588.2% Upside
$10.67 Price Target
Short Interest
Bearish
5.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Femasys in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.93) to ($0.74) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.45 out of 5 stars

Medical Sector

533rd out of 939 stocks

Surgical & Medical Instruments Industry

61st out of 97 stocks

FEMY stock logo

About Femasys Stock (NASDAQ:FEMY)

Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition, the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

FEMY Stock Price History

FEMY Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Chardan Capital Reiterates Buy Rating for Femasys (NASDAQ:FEMY)
Femasys' (FEMY) "Buy" Rating Reaffirmed at HC Wainwright
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Femasys (NASDAQ:FEMY) PT Raised to $10.00 at Jonestrading
Femasys Discloses Positive Data from FemaSeed Trial
Femasys Stock (NASDAQ:FEMY), Short Interest Report
See More Headlines
Receive FEMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Femasys and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Next Earnings (Estimated)
4/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:FEMY
Fax
N/A
Employees
34
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.67
High Stock Price Target
$12.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+588.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-11,390,000.00
Net Margins
-1,164.78%
Pretax Margin
-1,164.23%

Debt

Sales & Book Value

Annual Sales
$1.21 million
Book Value
$1.29 per share

Miscellaneous

Free Float
18,102,000
Market Cap
$33.56 million
Optionable
Not Optionable
Beta
-2.95
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Ms. Kathy Lee-Sepsick (Age 56)
    Founder, President, CEO & Director
    Comp: $453.58k
  • Mr. Dov Elefant (Age 57)
    Chief Financial Officer
    Comp: $355.72k
  • Mr. Daniel Scott Currie (Age 60)
    COO, Senior VP & Secretary
    Comp: $352.55k
  • Ms. Mary An Merchant J.D.
    Ph.D., Vice President of Counsel & Intellectual Property
  • Dr. Jeffrey Marcus M.D.
    M.S., Chief Medical Advisor
  • Ms. Christine Thomas (Age 51)
    Senior VP of Regulatory & Clinical Affairs
  • Dr. James H. Liu M.D.
    Chief Medical Officer
  • Mr. Richard Spector
    Chief Commercial Officer

FEMY Stock Analysis - Frequently Asked Questions

Should I buy or sell Femasys stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Femasys in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" FEMY shares.
View FEMY analyst ratings
or view top-rated stocks.

What is Femasys' stock price target for 2024?

3 analysts have issued 1-year price targets for Femasys' shares. Their FEMY share price targets range from $10.00 to $12.00. On average, they anticipate the company's share price to reach $10.67 in the next twelve months. This suggests a possible upside of 588.2% from the stock's current price.
View analysts price targets for FEMY
or view top-rated stocks among Wall Street analysts.

How have FEMY shares performed in 2024?

Femasys' stock was trading at $0.9750 at the beginning of 2024. Since then, FEMY stock has increased by 59.0% and is now trading at $1.55.
View the best growth stocks for 2024 here
.

Are investors shorting Femasys?

Femasys saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,120,000 shares, an increase of 124.1% from the February 29th total of 499,700 shares. Based on an average daily trading volume, of 680,100 shares, the days-to-cover ratio is presently 1.6 days. Approximately 5.6% of the company's stock are short sold.
View Femasys' Short Interest
.

When is Femasys' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our FEMY earnings forecast
.

How were Femasys' earnings last quarter?

Femasys Inc. (NASDAQ:FEMY) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.04. The business earned $0.27 million during the quarter. Femasys had a negative net margin of 1,164.78% and a negative trailing twelve-month return on equity of 100.01%.

When did Femasys IPO?

Femasys (FEMY) raised $35 million in an IPO on Friday, June 18th 2021. The company issued 2,700,000 shares at a price of $12.00-$14.00 per share. Chardan and JonesTrading acted as the underwriters for the IPO.

Who are Femasys' major shareholders?

Femasys' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (0.72%), Vanguard Group Inc. (0.72%) and Northern Trust Corp (0.36%).
View institutional ownership trends
.

How do I buy shares of Femasys?

Shares of FEMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FEMY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners